Dr. Anthony Fauci will see data from government-funded vaccine trials before the FDA does. One caveat: Pfizer’s study, which is ahead of the others, isn’t included in his purview.
by Isaac Arnsdorf, Caroline Chen and Ryan Gabrielson
There is a small chance that Pfizer’s vaccine trial will yield results by Nov. 3. But it could still take weeks for FDA review. Here’s everything that has to happen and how to tell a political stunt from a real vaccine.
by Caroline Chen, Isaac Arnsdorf and Ryan Gabrielson
How the world’s greatest public health organization was brought to its knees by a virus, the president and the capitulation of its own leaders, causing damage that could last much longer than the coronavirus.
by James Bandler, Patricia Callahan, Sebastian Rotella and Kirsten Berg
Most rejected applications were deemed duplicates because voters had unwittingly checked a request box during the primary. The administrative nightmare highlights the difficulty of ramping up mail-in voting on the fly.
by Ryan McCarthy and Derek Willis, ProPublica, and Jonathan Lai, The Philadelphia Inquirer
ProPublica and The Guardian are tracking mail-in votes in battleground states — how many have been requested, how many have been returned and how many have been rejected.
Local law enforcement officers deputized as U.S. Marshals have given conflicting accounts of the shooting. Witnesses say they heard no warning before the agents shot Michael Reinoehl dead, an outcome President Trump termed “retribution.’’
by Bryan Denson for ProPublica and Conrad Wilson, Oregon Public Broadcasting
Trump’s trade representative joined the administration with one mission: Bring factory jobs back from overseas. The results so far? Endless trade wars, alienated allies, and a manufacturing recession.
Was this email forwarded to you from a friend?
Subscribe.
This email was sent to [email protected]. Update your
email preferences or unsubscribe
to stop receiving this newsletter. Email not displaying correctly?
View it in your browser.
